Donate Help Contact The AHA Sign In Home
American Heart Association
Stroke
Search: search_blue_button Advanced Search
Published Online
on March 1, 2007

Stroke. 2007
Published online before print March 1, 2007, doi: 10.1161/01.STR.0000259887.70358.e0
A more recent version of this article appeared on April 1, 2007
This Article
Right arrow Full Text (PDF)
Right arrow All Versions of this Article:
38/4/1354    most recent
01.STR.0000259887.70358.e0v1
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrowRequest Permissions
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Ogawa, T.
Right arrow Articles by Date, I.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Ogawa, T.
Right arrow Articles by Date, I.
Related Collections
Right arrow Cerebral Aneurysm, AVM, & Subarachnoid hemorrhage
Right arrow Other Stroke Treatment - Medical

Submitted on November 15, 2006
Accepted on November 21, 2006

Novel Protein Transduction Method by Using 11R. An Effective New Drug Delivery System for the Treatment of Cerebrovascular Diseases

Tomoyuki Ogawa MD*; Shigeki Ono MD, PhD; Tomotsugu Ichikawa MD, PhD; Seiji Arimitsu MD; Keisuke Onoda MD, PhD; Koji Tokunaga MD, PhD; Kenji Sugiu MD, PhD; Kazuhito Tomizawa MD, PhD; Hideki Matsui MD, PhD; and Isao Date MD, PhD

From Departments of Neurological Surgery (T.O., S.O., T.I., S.A., K.O., K.T., K.S., I.D.) and Physiology (K.T., H.M.), Okayama University Graduate School of Medicine, Dentistry, and Pharmaceutical Sciences, Shikata-cho, Okayama, Japan.

* To whom correspondence should be addressed. E-mail: tom{at}md.okayama-u.ac.jp.

Background and Purpose--A motif of 11 consecutive arginines (11R) is reported to be one of the most effective protein transduction domains for introducing proteins into the cell membrane. We therefore examined the transduction efficiency of 11R in cerebral arteries.

Methods--Basilar arteries (BAs) obtained from rats were incubated with either 11R-enhanced green fluorescent protein (11R-EGFP) or EGFP without 11R. After incubation, expression of 11R-EGFP or EGFP in BA serial sections was observed by fluorescence microscope. In an additional in vivo experiment, 11R-EGFP or EGFP was injected into the cisterna magna with or without subarachnoid hemorrhage. The 11R-EGFP or EGFP was injected just after the autologous blood injection, and then the expression of 11R-EGFP or EGFP in BA sections was also observed by fluorescence microscope.

Results--The 11R-EGFP signal was much stronger than that of EGFP in all layers of the rat BA, in both in vivo and ex vivo experiments. Moreover, the 11R-EGFP was transduced into the BA immediately (2 hours after the injection). Interestingly, 11R-fused fluorescent protein was transduced especially into the tunica media of the BA.

Conclusions--The 11R-fused fluorescent protein effectively penetrates into all layers of the rat BA, especially into the tunica media. This is the first study to our knowledge to demonstrate the successful transduction of a protein transduction domain fused protein into the cerebral arteries.


Key words: cerebral vasospasm • cerebrovascular disease protein • enhanced green fluorescence protein • transduction domain




This article has been cited by other articles:


Home page
StrokeHome page
T. Baba, M. Kameda, T. Yasuhara, T. Morimoto, A. Kondo, T. Shingo, N. Tajiri, F. Wang, Y. Miyoshi, C. V. Borlongan, et al.
Electrical Stimulation of the Cerebral Cortex Exerts Antiapoptotic, Angiogenic, and Anti-Inflammatory Effects in Ischemic Stroke Rats Through Phosphoinositide 3-Kinase/Akt Signaling Pathway
Stroke, November 1, 2009; 40(11): e598 - e605.
[Abstract] [Full Text] [PDF]